MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, comprising medicines, vitamins, medical devices, and test kits; and offers consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company also provides wholesale cash and carry; diagnostic, pathological, and laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry, as well as online platform. The company was incorporated in 2006 and is based in Hyderabad, India.
Revenue projections:
Revenue projections for MEDPLUS With MEDPLUS's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.
Financial Ratios:
currentRatio
0.00000
forwardPE
47.44249
debtToEquity
62.95500
earningsGrowth
2.35100
revenueGrowth
0.08300
grossMargins
0.23086
operatingMargins
0.04487
trailingEps
11.03000
forwardEps
15.12000
MEDPLUS's forward EPS is higher than its trailing EPS, which signals that the company is expected to achieve greater profitability this financial year. This suggests improved earnings performance, indicating a positive outlook for MEDPLUS's financial growth.
Price projections:
Price projections for MEDPLUS Price projections for MEDPLUS have been revised upward over time, signaling increasing optimism about the company's future. This steady increase reflects a positive outlook for MEDPLUS's growth and market performance.
Recommendation changes over time:
Recommendations trend for MEDPLUS
MedPlus Health Services Limited has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view MedPlus Health Services Limited as a stable option to park their money and potentially benefit from the company's continued growth and profitability.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
This article explores the Reserve Bank of India's initiatives aimed at enabling...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.